Clinical Trial Update: Efficacy, Safety and Immunogenicity Study of GlaxoSmithKline(GSK) Biologicals' Candidate Malaria Vaccine 257049 in the Sporozoite Challenge Model in Healthy Malaria-naïve Adults [Phase 2]

View source ↗

Summary

Phase 2 trial assessing efficacy, safety, and immunogenicity of a GlaxoSmithKline malaria vaccine candidate in healthy malaria-naïve adults; results posted afte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Malaria vaccine 257049

Snippet

Sponsor: GlaxoSmithKline | Conditions: Malaria | Phase 2 | Status: COMPLETED | Results posted: 2018-12-26